Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Vasudev Bailey
AddedFeb 15, 2024
UpdatedMay 31, 2026
Vasudev Bailey

Vasudev Bailey

Board Member, Aether Bio

CrunchbaseLinkedIn

Vasudev Bailey's Career

Aether Bio
Aether Bio

Menlo Park, CA, US

Board Member· Board
Unnatural Products
Unnatural Products

Santa Cruz, CA, US

Board Member· Board
Delix Therapeutics
Delix Therapeutics

Boston, MA, US

Board Member· Board
Eko Health
Eko Health

Emeryville, CA, US

Board Member· Board
Excision BioTherapeutics
Excision BioTherapeutics

Philadelphia, PA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Vasudev Bailey's Career

Aether Bio
Aether Bio
Series A$49.1M932017Menlo Park, CA, US
Board Member· Board

Leadership at Aether Bio

Pavle JeremicPavle JeremicFounder

Similar to Aether Bio

Aperiam BioAperiam BioAustin, TX, USProtein Optimizationest. 2021Aperiam BioAustin, TX, US · est. 2021

Aperiam Bio: Innovating protein optimization with enzyme engineering partnerships.

Seed · $12.7M8
AI ProteinsAI ProteinsBoston, MA, USProtein Therapeuticsest. 2021AI ProteinsBoston, MA, US · est. 2021

AI Proteins: A biotech firm specializing in the design and engineering of synthetic mini protein therapeutics.

Series B · $18.2M44
EvozyneEvozyneChicago, IL, USProtein Engineeringest. 2020EvozyneChicago, IL, US · est. 2020

Evozyne: Merging evolution and AI to amplify protein functions for therapeutics and sustainability solutions.

Series B · $144.4M175
Profluent BioProfluent BioBerkeley, CA, USProtein Designest. 2022Profluent BioBerkeley, CA, US · est. 2022

Profluent Bio: An AI-driven firm specializing in designing innovative proteins for industry use.

Seed · $9M4
Unnatural Products
Unnatural Products
Series A$38M362017Santa Cruz, CA, US
Board Member· Board

Leadership at Unnatural Products

Cameron PyeCameron PyeCo-Founder
Joshua SchwochertJoshua SchwochertCo-Founder
Michael AbermanMichael AbermanBoard Member

Similar to Unnatural Products

NeomorphNeomorphSan Diego, CA, USDrug Discoveryest. 2020NeomorphSan Diego, CA, US · est. 2020

Neomorph, a San Diego-based biotech firm, innovates new medicines to solve critical health issues.

Series A · $109M62
DeepCureDeepCureBoston, MA, USDrug Discoveryest. 2018DeepCureBoston, MA, US · est. 2018

DeepCure: Accelerating affordable AI-powered drug discovery for better, faster results.

Series A · $40M39
Model MedicinesModel MedicinesLos Angeles, CA, USDrug Discoveryest. 2019Model MedicinesLos Angeles, CA, US · est. 2019

Model Medicines: Accelerating drug discovery with AI, turning decades into days.

Seed · $4.1M22
Delix Therapeutics
Delix Therapeutics
Angel$118.3M252019Boston, MA, US
Board Member· Board

Leadership at Delix Therapeutics

David OlsonDavid OlsonCo-Founder
Mark RusMark RusCEO
Nick HaftNick HaftCo-Founder

Similar to Delix Therapeutics

Lykos TherapeuticsLykos TherapeuticsSan Jose, CA, USPharmaceuticalsest. 2014Lykos TherapeuticsSan Jose, CA, US · est. 2014

Lykos Therapeutics: Revolutionizing mental health with innovative, science-backed psychedelic therapies.

Series A · $100M175
Lusaris TherapeuticsLusaris TherapeuticsBoston, MA, USTherapeuticsest. 2021Lusaris TherapeuticsBoston, MA, US · est. 2021

Lusaris: A biotech firm pioneering advanced therapeutics for severe neuropsychiatric disorders.

Series A · $60M6
Denali TherapeuticsDenali TherapeuticsSan Francisco, CA, USBiotechest. 2015Denali TherapeuticsSan Francisco, CA, US · est. 2015

Denali Therapeutics, a US-based biotech firm, develops medicines for neurodegenerative diseases.

Public · $622M427
Eko Health
Eko Health
Seed$128.2M1532013Emeryville, CA, US
Board Member· Board

Recent news

EGYM, a connected fitness startup conceived after the founder hit a wall at the gym, lands $200M at a $1.2B+ valuationTechCrunch · 2024

Leadership at Eko Health

Connor LandgrafConnor LandgrafCEO
Corey MulloyCorey MulloyBoard Member
Julien ArtiguesJulien ArtiguesCo-Founder
Jason BelletJason BelletBoard Member
Tyler CrouchTyler CrouchCo-Founder
Ryan DrantRyan DrantBoard Member
Excision BioTherapeutics
Excision BioTherapeutics
Series A$77.6M512015Philadelphia, PA, US
Board Member· Board

Leadership at Excision BioTherapeutics

Tom MalcolmTom MalcolmCo-Founder
Nicole PaulkNicole PaulkBoard Member
William CarsonWilliam CarsonBoard Member
Daniel DornbuschDaniel DornbuschBoard Member
Ashok KrishnamurthiAshok KrishnamurthiBoard Member
Jeff KindlerJeff KindlerBoard Member

Similar to Excision BioTherapeutics

TherabiolTherabiolSan Francisco, CA, USImmune Therapiesest. 2012TherabiolSan Francisco, CA, US · est. 2012

Therabiol, Inc.: A San Francisco-based biotech firm specializing in developing immune therapies for viral infections.

Seed · $150k5
ExcepgenExcepgenSan Francisco, CA, USGene Therapies, Vaccinesest. 2018ExcepgenSan Francisco, CA, US · est. 2018

ExcepGen: A San Francisco-based biotech firm innovating in drug discovery for next-gen therapeutics.

Seed · $4.2M6
Exegenesis BioExegenesis BioLansdale, PA, USGene Therapyest. 2019Exegenesis BioLansdale, PA, US · est. 2019

Exegenesis: A global leader in gene therapy, innovating new medicines for China and worldwide.

Series B · $10M17
RegenxbioRegenxbioRockville, MD, USGene Therapyest. 2008RegenxbioRockville, MD, US · est. 2008

REGENXBIO Inc., a global biotech firm, specializes in developing and commercializing gene therapy solutions.

Public · $638.2M401

Vasudev Bailey's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Vasudev Bailey

Elon BomsElon BomsBoard Member · LaunchCapitalLuis VeraLuis VeraFounder · ScopixGaurav SharmaGaurav SharmaFounder · Saas LabsRafał AgnieszczakRafał AgnieszczakBoard Member · AbstraArjun SundararajanArjun SundararajanCo-Founder · AmbitJuha ChristensenJuha ChristensenBoard Member · Blazar Capital